Get A Comprehensive Insight Into Japan's Pharmaceutical Market
DUBLIN, Ireland--(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/reports/c88046) has announced the addition of "IMS World Review Country Profile - Japan" to their offering. IMS Health's Country Profiles provide a comprehensive insight into the national sales of the pharmaceutical market in selected countries over 5 years. Each individual IMS Company Profile analyzes the critical components that make up a pharmaceutical company, providing you with a clear assessment of the relative strengths and weaknesses of a company's business strategy. Sales performance is analysed in terms of geographic region, major corporations, therapeutic classes, major products and new product activity. All data is available over a 5 year period for easy trend analysis and is based on Quarter 4 sales figures. Country Profiles are available for: Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Czech Republic, Egypt, Finland, France, Germany, India, Indonesia, Italy, Mexico, Netherlands, Poland, Portugal, Russian Federation, South Africa, South Korea, Spain, Switzerland, Taiwan, Turkey, United Kingdom and United States. -0- *T Products Mentioned: Blopress Diovan Epogin Gaster Leuplin Lipitor Mevalotin Mohrus Hisamitsu Norvasc Nu Lotan Companies Mentioned: -Takeda Yakuhin Kog -Pfizer -Chugai Seiyaku -Astellas Seiyaku -Novartis Pharma -Eisai -Daiichi Seiyaku -Sankyo -Glaxosmithkline -Dainippon Sumitomo -Otsuka Seiyaku -Mitsubishi Pharma -Astrazeneca -Banyu Seiyaku -Shionogi Seiyaku -Tanabe Seiyaku -Ono Yakuhin Kogyo -Nippon Boehringer -Sanofi-Aventis -Taiho Yakuhin Kogy -Kyowa Hakko Kogyo -Abbott Japan -Santen Seiyaku -Hisamitsu Seiyaku -Bayer Yakuhin -Taisho Toyama Iyak -Eli Lilly Japan -Schering-Plough -Meiji Seika -Tsumura -Kowa Soyaku -Novo Nordisk Pharm -Bristol-Myers -Mochida Seiyaku -Kaken Seiyaku *T For more information, visit http://www.researchandmarkets.com/reports/c88046. Research and Markets Laura Wood Senior Manager Fax: +353 1 4100 980 press@researchandmarkets.com Copyright Business Wire 2008
© Thomson Reuters 2009 All rights reserved




